950210.KS
Prestige BioPharma Limited
KSC · Healthcare · Biotechnology · SG
KRW 4,155.00
−1.54%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.58x
- Price / sales
- 9.58x
- Price / cash flow
- -4.48x
Enterprise value
- Enterprise value
- KRW 365.5B
- EV / sales
- 14.02x
- EV / EBITDA
- -6.02x
- EV / EBIT
- -3.91x
- Market cap
- KRW 249.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026